Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06499389

Instrumental Respiratory Physiotherapy in Difficult-to-wean ICU Patients

Difficult ventilatory weaning is associated with a 20% mortality rate. 40% of these patients will develop intensive care unit (ICU)-acquired neuromyopathy, associated with reduced cough strength and a 4-fold increase in the risk of reintubation. The objective measure of cough strength is peak expiratory flow (PEF). Instrument-assisted coughing is a respiratory physiotherapy technique capable of significantly increasing PEF in chronic neuromuscular patients and draining bronchial secretions.

The objective of the study is to determine whether an early, systematic, instrumental, intensive respiratory physiotherapy strategy in patients with difficult ventilatory weaning and ICU-acquired neuromyopathy significantly improves PEF immediately prior to extubation, compared with a conventional, protocolized management strategy.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Service d'Anesthésie et Réanimation, Hôpital de la Croix Rousse, GHN, Lyon, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient 18 years or more, affiliated to a social security system
  • Patients on invasive mechanical ventilation for 48 hours or more
  • Failure of at least one mechanical ventilation weaning test (spontaneous breathing trial, SBT)
  • First successful SBT on the day of eligibility assessment
  • Medical Research Council (MRC) score < 48 and/or cough strength ≤ 2 on the 6-point Likert scale

Exclusion criteria

  • Recent brain injury (< 3 months, stroke, cardiopulmonary arrest)
  • Delirium tremens (Cushman score > 7)
  • Chronic neuromuscular pathology
  • Patient under continuous intravenous sedation
  • Patient unresponsive to simple commands and Richmond Agitation and Sedation Scale (RASS) score < -2 or > +1
  • FiO2: Inspired Oxygen Fraction> 50%, percutaneous, O2: oxygen saturation < 88%, positive end-expiratory pressure > 5 centimeter of water (cmH2O) or respiratory rate ≥ 35 min-1
  • Vasopressor catecholamine at a dose > 0.5 μg/kg/min
  • Tracheostomized patient
  • Undrained pneumothorax
  • Pulmonary emphysema (identified as antecedent in medical record)
  • Uncontrolled hemoptysis
  • Surgery < 3 months of esophagus and/or the ear, nose and throat (ENT) sphere
  • Pregnancy or lactating
  • Patient deprived of liberty by judicial or administrative decision
  • Patient under guardianship or curatorship
  • Patient already included in the same study or in another study sharing the same primary endpoint

Treatment and study plan

Systematic and early intensive instrumental respiratory physiotherapy for patients undergoing difficult ventilatory weaning

Procedure

Patients randomized to this group will receive 3 sessions per day of intensive early respiratory physiotherapy with instrumental techniques from randomization to day 7, before and after any extubation. The strategy will be applied until day 7 of randomization, regardless of the patient's status (intubated or not).

Protocolized standard-of-care respiratory physiotherapy

Procedure

Patients in this group will receive standardized and protocolized respiratory physiotherapy to reproduce the usual practices of non-expert centers,1 to 2 sessions of manual respiratory physiotherapy (not assisted by an instrumental technique) per day until the day of successful extubation, or until day 7 if necessary

Primary outcomes

  1. Unassisted peak expiratory cough flow (PECF) under mechanical ventilation during a voluntary coughing effort

    Time frame: At Hour 24

    PECF measured on the ventilator using its built-in flowmeter (PECF on unassisted coughing under mechanical ventilation). PECF is expressed in L/min.

Secondary outcomes

  1. Unassisted PECF after disconnection from mechanical ventilation during a voluntary coughing effort

    Time frame: At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7

    PECF measured by a spirometer without ventilation, either in intubated patients after disconnection from the ventilator, and in extubated patients by application of a naso-buccal mask connected to the spirometer. PECF is expressed in L/min.

  2. Assisted PECF under mechanical ventilation

    Time frame: At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7

    PECF measured by the spirometer during the application of mechanical (instrumental) cough assistance by connecting the spirometer between the intubation tube and the Cough Assist E70 in the intubated patient, or between the nasobuccal mask and the Cough Assist E70 in the extubated patient. PECF is expressed in L/min.

  3. Semi-quantitative measurement of cough strength

    Time frame: At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7

    Measurements of cough strength using a 6-level Likert scale (0-5) for intubated patients.

  4. Semi-quantitative measurement of cough strength

    Time frame: At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7

    Measurements of cough strength using a 4-level Likert scale (0-3) for extubated patients.

  5. Semi-quantitative measurement of bronchial secretion quantity

    Time frame: At Hour 24, Day 2, Day 3, Day 4, Day 5, Day 6, Day 7

    Measurements of bronchial secretion quantity using a 5-level Likert scale (0 to 4). The intensity of bronchial secretion quantity is graded semi-quantitatively by observing the quantity of secretions mobilized and/or present in the patient's airways.

  6. Rate of hemodynamic instability episodes

    Time frame: At Hour 24 and after every respiratory physiotherapy session

    Number of physiotherapy sessions with mean arterial pressure < 65 mmHg. Hemodynamic instability is defined as the appearance of mottles, a mean arterial pressure < 65 mm Hg and requiring urgent intervention.

  7. Ratio of arterial oxygen partial pressure to fractional inspired oxygen (O2)

    Time frame: At Hour 24, Day 7

    Ratios of arterial partial pressure in O2 to inspired fraction in O2 measured on the ventilator (P/F ratio). In extubated, non-ventilated patients, fraction of inspired oxygen (FiO2) will be estimated using the following formula: 〖fraction inspired oxygen (FiO)〗_2 (%)=21+O2 flow (in L/min)× 3. Partial oxygen pressure (PaO2) is measured on arterial blood gas.

  8. Barotrauma complication rates

    Time frame: At Hour 24, Day 7

    Rate of barotraumatic complications. Thoracic (X-ray or computed tomography (CT) scan for pneumomediastinum and pneumothorax) or clinical examination (subcutaneous emphysema).

  9. Reintubation rate

    Time frame: At Hour 24, Day 7

    Rate of reintubation

  10. Number of days with invasive mechanical ventilation

    Time frame: Up to 60 days

    Time, in days, between inclusion and successful liberation from the ventilator

  11. Ventilator-free days (VFD)

    Time frame: Up to 60 days

    Time alive and free from invasive mechanical ventilation. A VFD of 0 is adjudicated to patients who died over that period, even if they were liberated from mechanical ventilation.

  12. Length of stay in intensive care unit

    Time frame: Up to 60 days

    Elapsed time, in days, between inclusion and ICU discharge

Study contacts

Contact information is provided by the study sponsor or research team.

Laurent BITKER, MD, PhD

CONTACT

[email protected]

04 26 10 94 93 ext. +33

Maria CLEYET, MSc

CONTACT

[email protected]

04 26 10 94 93 ext. +33

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Randomized Controlled Trial Evaluating the Impact of Intensive, Instrumental and Early Respiratory Physiotherapy on Peak Expiratory Flow in Mechanically Ventilated Patients With ICU-acquired Muscle Weakness

Acronym: PHYSIO WEAN

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jul 12, 2024
Registry last updated
Jan 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.